高级检索
当前位置: 首页 > 详情页

Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
本院角色:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究单位: [1]Sunshine Lake Pharma Co., Ltd. [2]Union Hospital Affiliated with Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China, 430022 [3]Tongji Hospital Affiliated to Tongji Medical College of Huazhong University Science & Technology Wuhan, Hubei, China, 430030 [4]Xiangya Hospital, Central South University Changsha, Hunan, China, 410008 [5]The People's Liberation Army No.81 Hospital Nanjing, Jiangsu, China, 210002 [6]The Second Hospital of Nanjing Nanjing, Jiangsu, China, 210003 [7]Nanjing, Jiangsu, China, 210008 [8]The Third People's Hospital of Zhenjiang Zhenjiang, Jiangsu, China, 212004 [9]The first hospital of jilin university Chang chun, Jilin, China, 130012 [10]The second hospital of jilin university Changchun, Jilin, China, 130041 [11]Qingdao municipal hospital Qingdao, Shandong, China, 266011 [12]Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai, China, 200020 [13]Huashan Sub-Hospital of Fudan University Shanghai, Shanghai, China, 200040 [14]Shanghai putuo district central hospital Shanghai, Shanghai, China, 200062 [15]Shanghai Public Health Clinical Center Shanghai, Shanghai, China, 201500

关键词: Chronic HBeAg positive HBV Infection

研究目的:
The experiment is divided into two parts: Part 1 and Part 2.Part 1 was the initial treatment patient and Part 2 was the treated patient.

资源点击量:426 今日访问量:2 总访问量:410 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)